ロード中...
CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial
BACKGROUND: The inflammatory response after aneurysmal subarachnoid haemorrhage (aSAH) has been associated with early brain injury, delayed cerebral ischaemia, poor functional outcome, and case fatality. In experimental SAH studies, complement C5 antibodies administered shortly after SAH reduced bra...
保存先:
| 出版年: | Trials |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7687754/ https://ncbi.nlm.nih.gov/pubmed/33239044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04838-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|